QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

The Journal of Neuroscience, March 23, 2005, 25(12):3229-3233; doi:10.1523/JNEUROSCI.0332-05.2005

This Article Full Text Full Text (PDF) Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (8) Citing Articles via Google Scholar Google Scholar Articles by Roy, S. Articles by Loh, H. H. Search for Related Content PubMed PubMed Citation Articles by Roy, S. Articles by Loh, H. H.

 Previous Article  |  Next Article 

BRIEF COMMUNICATION
In Vivo Activation of a Mutant µ-Opioid Receptor by Naltrexone Produces a Potent Analgesic Effect But No Tolerance: Role of µ-Receptor Activation and -Receptor Blockade in Morphine Tolerance

Sabita Roy, Xiaohong Guo, Jennifer Kelschenbach, Yuxiu Liu, and Horace H. Loh

Department of Pharmacology, University of Minnesota, Minneapolis, Minnesota 55455

Opioid analgesics are the standard therapeutic agents for the treatment of pain, but their prolonged use is limited because of the development of tolerance and dependence. Recently, we reported the development of a µ-opioid receptor knock-in (KI) mouse in which the µ-opioid receptor was replaced by a mutant receptor (S196A) using a homologous recombination gene-targeting strategy. In these animals, the opioid antagonist naltrexone elicited antinociceptive effects similar to those of partial agonists acting in wild-type (WT) mice; however, development of tolerance and physical dependence were greatly reduced. In this study, we test the hypothesis that the failure of naltrexone to produce tolerance in these KI mice is attributable to its simultaneous inhibition of -opioid receptors and activation of µ-opioid receptors. Simultaneous implantation of a morphine pellet and continuous infusion of the -opioid receptor antagonist naltrindole prevented tolerance development to morphine in both WT and KI animals. Moreover, administration of SNC-80 [(+)-4-[(R)--((2S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl]-N,N-diethylbenzamide], a agonist, in the naltrexone-pelleted KI animals resulted in a dose-dependent induction in tolerance development to both morphine- and naltrexone-induced analgesia. We conclude that although simultaneous activation of both µ- and -opioid receptors results in tolerance development, µ-opioid receptor activation in conjunction with -opioid receptor blockade significantly attenuates the development of tolerance.

Key words: morphine; tolerance; naltrexone; SNC-80; naltrindole; knock-in animals

---

Received May 25, 2004; revised February 17, 2005; accepted February 18, 2005.

This article has been cited by other articles:

				S. L. Chen, H. I. Ma, J. M. Han, P. L. Tao, P. Y. Law, and H. H. Loh dsAAV type 2-mediated gene transfer of MORS196A-EGFP into spinal cord as a pain management paradigm PNAS, December 11, 2007; 104(50): 20096 - 20101. [Abstract] [Full Text] [PDF]

				Y. L. Chen, P.-Y. Law, and H. H. Loh Sustained Activation of Phosphatidylinositol 3-Kinase/Akt/Nuclear Factor {kappa}B Signaling Mediates G Protein-coupled {delta}-Opioid Receptor Gene Expression J. Biol. Chem., February 10, 2006; 281(6): 3067 - 3074. [Abstract] [Full Text] [PDF]

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help